Size reduction and living lobar transplantation

G. Massard (Strasbourg, France)

Source: ERS Course 2016
Number: 8

Slide presentationWebcastMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Massard (Strasbourg, France). Size reduction and living lobar transplantation. ERS Course 2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Living-donor lobar transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=257
Year: 2003

Alternatives to lung donor shortage
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=89
Year: 2004

Lung transplantation: the ideal treatment for diffuse disease?
Source: Annual Congress 2006 - Up to date management of bronchiectasis
Year: 2006

Paediatric lung transplantation
Source: Eur Respir J 2004; 24 : 839-845
Year: 2004

Rapid decline in lung disease other than COPD: when should lung transplantation be considered?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007

Survival benefit of lung transplantation for cystic fibrosis in Norway
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019

Progressive TLC loss after unilateral lung transplantation in IPF: Functional respiratory imaging differentiates between transplanted and native lung
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015

Selection of emphysema patients for lung transplantation today
Source: Annual Congress 2004 - Lung transplantation: new insights in advanced lung disease and new drug developments - do they impact on selection criteria?
Year: 2004

Paediatric lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=243
Year: 2003

Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Relative indications of volume reduction and transplantation in patients with severe emphysema
Source: Annual Congress 2003 - Relative indications of volume reduction and transplantation in patients with severe emphysema
Year: 2003

Idiopathic pulmonaryfibrosis: the native lung after single lung transplantation
Source: Eur Respir J 2003; 22: Suppl. 45, 328s
Year: 2003

Low BMI in emphysema patients: A contraindication for lung transplantation?
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012

Fungal re-colonization in cystic fibrosis or bronchiectasis patients after lung transplantation: Incidence, time of onset and related-factors
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014

Mortality risk and pulmonary function in adults with cystic fibrosis at time of wait listing for lung transplantation in the United States
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015

Lung transplantation for cystic fibrosis – ten years‘ experience in Hungary
Source: Eur Respir J 2007; 30: Suppl. 51, 386s
Year: 2007

Uncontrolled non-heart-beating donors vs. brain dead donors in lung transplantation: Comparison of early and late results
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Lung transplantation (LTx) for fibrotic diseases: a single centre experience
Source: Eur Respir J 2005; 26: Suppl. 49, 635s
Year: 2005

Lung transplantation
Source: Procedure Video 2011
Year: 2011